On 2025-05-12, Akero Therapeutics, Inc. (AKRO) announced earnings per share of $0.90 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.01.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-0.95 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-1.01 | $0.90 |
| 2025-02-28 | 2024-12-31 | $-1.14 | $-0.99 |
| 2024-11-08 | 2024-09-30 | $-0.90 | $-1.05 |
| 2024-08-09 | 2024-06-30 | $-0.90 | $-0.81 |
| 2024-05-10 | 2024-03-31 | $-0.90 | $-0.90 |
| 2024-02-29 | 2023-12-31 | $-0.82 | $-0.99 |
| 2023-11-13 | 2023-09-30 | $-0.69 | $-0.71 |
| 2023-08-11 | 2023-06-30 | $-0.62 | $-0.60 |
| 2023-05-15 | 2023-03-31 | $-0.62 | $-0.55 |
| 2023-03-17 | 2022-12-31 | $-0.78 | $-0.49 |
| 2022-11-04 | 2022-09-30 | $-0.73 | $-0.92 |
| 2022-08-04 | 2022-06-30 | $-0.85 | $-0.77 |
| 2022-05-06 | 2022-03-31 | $-0.85 | $-0.74 |
| 2022-02-25 | 2021-12-31 | $-0.81 | $-0.93 |
| 2021-11-12 | 2021-09-30 | $-0.91 | $-0.70 |
| 2021-08-13 | 2021-06-30 | $-0.72 | $-0.83 |
| 2021-05-13 | 2021-03-31 | $-1.01 | $-0.43 |
| 2021-03-16 | 2020-12-31 | $-0.72 | $-0.86 |
| 2020-11-12 | 2020-09-30 | $-0.48 | $-0.63 |
| 2020-08-12 | 2020-06-30 | $-0.48 | $-0.57 |
| 2020-05-13 | 2020-03-31 | $-0.60 | $-0.42 |
| 2020-03-16 | 2019-12-31 | $-0.59 | $-0.55 |
| 2019-11-12 | 2019-09-30 | $-0.43 | $-0.56 |
| 2019-08-12 | 2019-06-30 | $-0.36 | $-2.21 |